Obesity ups odds that prostate cancer will recur

Key points
- Men who gain weight rapidly between the ages of 25 and 40 are twice as likely to experience a recurrence of Prostate cancer after surgery as men who keep the pounds off, research suggests.
- The cause of prostate cancer is unknown, although some studies have shown a relationship between high dietary fat intake and increased testosterone levels.
- "At any age, but especially in the adult population, keeping a healthy weight and diet will not only help Prostate cancer patients to potentially reduce the chance of the cancer to recur, but will also reduce their risk of cardiovascular disease and Diabetes," said Dr.
- After removal of the prostate gland, the PSA level should be undetectable.
Men who gain weight rapidly between the ages of 25 and 40 are twice as likely to experience a recurrence of Prostate cancer after surgery as men who keep the pounds off, research suggests. Men who are obese at age 40 and at the time of Prostate cancer diagnosis also have a higher risk of recurrence.
"At any age, but especially in the adult population, keeping a healthy weight and diet will not only help Prostate cancer patients to potentially reduce the chance of the cancer to recur, but will also reduce their risk of cardiovascular disease and Diabetes," said Dr. Sara S. Strom from The University of Texas M.D. Anderson Cancer Center, Houston.
Strom and colleagues evaluated self-reported measures of Obesity at different ages in a group of 526 Prostate cancer patients treated with radical prostatectomy (removal of the prostate) in an effort to predict biochemical failure, which is the increase in PSA levels in the blood after removal of the prostate, the primary source of this protein. After removal of the prostate gland, the PSA level should be undetectable.
Prostate cancer involves a malignant tumor growth within the prostate gland.
Causes, incidence, and risk factors
The cause of prostate cancer is unknown, although some studies have shown a relationship between high dietary fat intake and increased testosterone levels. When testosterone levels are lowered either by surgical removal of the testicles (castration, orchiectomy) or by medication, prostate cancer can regress. There is no known association with benign prostatic hyperplasia (BPH).
For more information check: Prostate cancer
Strom and colleagues report that men who were obese at the time of diagnosis had marginally higher rates of biochemical failure, but those who were obese at age 40 had significantly lower biochemical failure-free survival than did those who were not obese at age 40.
Obesity between age 25 and 40 was associated with more than a doubling of the biochemical failure risk, according to a report in the October 1st issue of Clinical Cancer Research, as was an annual weight gain in excess of about three and a half pounds per year between age 25 and the diagnosis of Prostate cancer.
Prostate cancer is the third most common cause of death from cancer in men of all ages and is the most common cause of death from cancer in men over 75 years old. Prostate cancer is rarely found in men younger than 40.Men at higher risk include black men older than 60, farmers, tire plant workers, painters, and men exposed to cadmium. The lowest incidence occurs in Japanese men and vegetarians.
Written and revised by
David Cohen, M.D.
Our doctors write and review articles for accuracy and keep them up to date.
health.am provides general information, not medical advice. Always consult a qualified health professional about your own health.
Explore health topics
More in this topic
Cancer →
NewsNew Model for Prostate Cancer Screening Reduces Biopsies
A new model for prostate cancer screening can significantly reduce the number of unnecessary biopsies and minimize detection of clinically insignificant disease in comparison with standard screening using prostate…
24 November 2015
NewsMore men at risk for prostate cancer as a result of less regular screening
The U.S. Preventive Services Task Force (USPSTF) recommendation against regular prostate specific antigen (PSA) screening for prostate cancer is controversial. While it may reduce the risk of over diagnosis and…
23 September 2015
NewsNew biomarker identified in breast and prostate cancers holds promise for treating disease
Cedars-Sinai researchers have identified a novel genetic biomarker responsible for the progression of many breast and prostate cancers. The finding could bolster efforts to better identify patients who respond to…




